Literature DB >> 9696879

The nucleolus is the site of Borna disease virus RNA transcription and replication.

J M Pyper1, J E Clements, M C Zink.   

Abstract

Borna disease virus (BDV) is a neurotropic nonsegmented negative-strand RNA virus with limited homology to rhabdoviruses and paramyxoviruses. A distinguishing feature of BDV is that it replicates in the nucleus of infected cells. Strand-specific probes used for in situ hybridization of infected rat brain showed that there was differential localization of positive- and negative-strand RNAs within the nucleus of neurons. Within nuclei, sense-strand RNAs were preferentially localized within nucleolar regions while genomic-sense RNAs were found in both nucleolar and nonnucleolar regions. These results suggested a role for the nucleolus in BDV replication. Nucleoli isolated from persistently infected neuroblastoma cells contained both genomic and antigenomic BDV RNA species as well as an enrichment of the 39/38-kDa and gp18 BDV proteins. Since the nucleolus is the site of rRNA transcription, we examined BDV transcription in the presence of inhibitors of RNA polymerase I. Inhibition of RNA polymerase I did not affect levels of BDV transcription.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696879      PMCID: PMC110048     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells.

Authors:  T Briese; J C de la Torre; A Lewis; H Ludwig; W I Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

2.  Nucleolar targeting signal of Rex protein of human T-cell leukemia virus type I specifically binds to nucleolar shuttle protein B-23.

Authors:  Y Adachi; T D Copeland; M Hatanaka; S Oroszlan
Journal:  J Biol Chem       Date:  1993-07-05       Impact factor: 5.157

3.  RNA splicing in Borna disease virus, a nonsegmented, negative-strand RNA virus.

Authors:  P A Schneider; A Schneemann; W I Lipkin
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Partial purification and characterization of Borna disease virions released from infected neuroblastoma cells.

Authors:  J M Pyper; J E Clements
Journal:  Virology       Date:  1994-06       Impact factor: 3.616

5.  Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present.

Authors:  B Cubitt; J C de la Torre
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Analysis of Borna disease virus-specific RNAs in infected cells and tissues.

Authors:  J A Richt; S Vande Woude; M C Zink; O Narayan; J E Clements
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

7.  Molecular mechanisms of visna virus Tat: identification of the targets for transcriptional activation and evidence for a post-transcriptional effect.

Authors:  S L Gdovin; J E Clements
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

8.  Sequence and genome organization of Borna disease virus.

Authors:  B Cubitt; C Oldstone; J C de la Torre
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  In vivo detection of snRNP-rich organelles in the nuclei of mammalian cells.

Authors:  M Carmo-Fonseca; R Pepperkok; B S Sproat; W Ansorge; M S Swanson; A I Lamond
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

10.  Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA.

Authors:  U Fischer; S Meyer; M Teufel; C Heckel; R Lührmann; G Rautmann
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

View more
  29 in total

1.  Unique motif for nucleolar retention and nuclear export regulated by phosphorylation.

Authors:  Frédéric Catez; Monique Erard; Nathalie Schaerer-Uthurralt; Karine Kindbeiter; Jean-Jacques Madjar; Jean-Jacques Diaz
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  A nucleolar TAR decoy inhibitor of HIV-1 replication.

Authors:  Alessandro Michienzi; Shirley Li; John A Zaia; John J Rossi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-10       Impact factor: 11.205

3.  Use of a U16 snoRNA-containing ribozyme library to identify ribozyme targets in HIV-1.

Authors:  Hoshang J Unwalla; Haitang Li; Shi-Yang Li; Danny Abad; John J Rossi
Journal:  Mol Ther       Date:  2008-04-01       Impact factor: 11.454

4.  RNA polymerase II-controlled expression of antigenomic RNA enhances the rescue efficacies of two different members of the Mononegavirales independently of the site of viral genome replication.

Authors:  Arnold Martin; Peter Staeheli; Urs Schneider
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Identification of a role for nucleolin in rabies virus infection.

Authors:  S Oksayan; J Nikolic; C T David; D Blondel; D A Jans; G W Moseley
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

6.  Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly.

Authors:  Joshua C Grieger; Stephen Snowdy; Richard J Samulski
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA.

Authors:  A Michienzi; L Cagnon; I Bahner; J J Rossi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

8.  Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division.

Authors:  T Wurm; H Chen; T Hodgson; P Britton; G Brooks; J A Hiscox
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  Interaction of the coronavirus nucleoprotein with nucleolar antigens and the host cell.

Authors:  Hongying Chen; Torsten Wurm; Paul Britton; Gavin Brooks; Julian A Hiscox
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

10.  Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy.

Authors:  Janet Chung; Jane Zhang; Haitang Li; Dominique L Ouellet; David L DiGiusto; John J Rossi
Journal:  Hum Gene Ther       Date:  2012-09-18       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.